Thank you Nathaniel Lawson DMD PhD, for the excellent investigation (University of Alabama) of the properties and performance of the Infinix™ Universal Composite and the valuable comparison to other leading brands in the market. Nobio is extremely proud of the findings!
Read MoreAt this year’s GNYDM, Nobio’s booth traffic benefitted from mention by notable KOLs including Dr. Robert Lowe, Dr. Gordon Christensen, Dr. Travis Nelson and others, as well as an aggressive publicity/support program. The 12,000 attendees made for a productive and busy meeting for Nobio.
Read MoreAmid the noise and haste of the mid-town Manhattan holiday season, a group of leading clinicians and academicians met for an exclusive, invitation-only, session during the Greater New York meeting. Sponsored by Nobio, the event featured a strategic company update by Ronen Raz, Nobio CEO, followed by an impactive technical briefing by Professor John Featherstone, Dean Emeritus of UCSF School of Dentistry.
Read MoreThank you, Dr. Trudy Lev-Dor, oral medicine specialist and a hospital dentistry consultant for Maccabi Dent, for providing an excellent lecture and hands-on training workshops introducing and demonstrating the new Infinix™ product line and its innovative technology.
Read MoreNobio’s Antibacterial Composites Receive FDA 510(k) Clearance for Addressing a Key Process in Tooth Decay
Clinical data show that Infinix composites significantly reduce tooth demineralization.
Kadima, Israel – September 8, 2020 -- Nobio Ltd. today announced it has received an additional FDA 510(k) clearance for the company’s Infinix™ family of dental composites. Clinical data supporting the company’s submission to the FDA demonstrated that Nobio Infinix antibacterial composites significantly reduce tooth demineralization, which is part of the caries-formation (tooth decay) process. Read more at FDAnews.com.
“The data further validates our technology which promises a breakthrough in restorative dentistry improving outcomes for dentists and their patients” said Yoram Ashery, Nobio CEO. Nobio’s Infinix composites incorporate its patented QASiTM particle technology, which has shown long lasting inhibition of bacterial growth at the margins of composite fillings. “Infinix gives dentists a new tool to fight recurrent caries which is the main cause of restoration failure” said Ashery.
Tooth decay is a process, where bacteria generate acids that dissolve teeth by causing demineralization (tooth mineral loss), which leads to cavitated lesions (caries). Recurrent caries, tooth decay that occurs under existing fillings, crowns, or onlays, is a major cause of premature restoration failure.
A clinical study was performed at the University of California, San Francisco (UCSF) to assess Infinix’ s antibacterial activity in slowing and reducing demineralization. This study, completed in March, was led by principal investigator Peter Rechmann, DMD, PhD, professor and director of the Clinical Sciences Research Group at the UCSF School of Dentistry, and President of the American Academy of Cariology. “Our study showed that mineral loss in teeth adjacent to Infinix composites was two-thirds less than for the standard composite material, indicating the potential for less recurrent decay, longer-lasting restorations and less natural tooth loss”, said Dr. Rechmann.
Prof. Ervin Weiss, DMD, Nobio’s CTO and co-founder, and Dean Emeritus of the School of Dentistry of Tel-Aviv University, added, “We believe Infinix is a major advancement for dentistry that will reduce the likelihood of restoration failures due to secondary caries with its associated discomfort and costs.”
Nobio plans to initiate commercial sales of its Infinix product line by the end of this year. Dentists interested in trying Infinix composites can reserve a free Starter Kit at www.Infinix.com.
About Nobio
Nobio is a material sciences company that redefines the field of antimicrobial products and solutions with its long-lasting, safe, and highly active novel particle technology. Nobio developed and is commercializing Infinix, the first line of dental materials with its revolutionary antimicrobial technology to address the main causes of dental treatment failure and tooth loss. Nobio is also working with leading medical, dental, consumer, and industrial manufacturers to bring long-lasting antimicrobial properties to a wide range of products and applications. For more information, visit www.nobio.com
UC Disclaimer
The information stated above was prepared by Nobio to report on research conducted on its product and reflects solely the opinion of Nobio. Nothing in this statement shall be construed to imply any support or endorsement of Nobio, or any of its products, by The Regents of the University of California, its officers, agents, and employees.
Contact
Hanna Elbaz
(844) INFINIX
hanna@nobio.com
Scott Maier, UCSF
(415) 463-0110
scott.maier@ucsf.edu
Nobio’s Infinix Antibacterial Composites Recognized as a 2020 Cellerant Best of Class Technology Award Winner
The Award is selected by a panel of the most prominent technology leaders in dentistry.
Kadima, Israel – September 3, 2020 -- Nobio Ltd. today announced that its Infinix family of composites has been selected as a 2020 Cellerant Best of Class Technology Award recipient in the emerging technology category. The Best of Class “Emerging” awards recognize innovative technologies that either define new product categories altogether or stand to challenge established category leadership. The “Emerging” designation is intended to alert the dental community to promising new technologies or companies that have the potential to greatly impact the standard of care in dentistry.
“Announcing the award winners is especially meaningful this year,” said Dr. Lou Shuman, CEO of Cellerant and founder of the Best of Class Technology Awards. "The Chicago Midwinter, where the Best of Class Panel selected the award winners, was really the last in person event for the dental community in 2020. Dentists and their staffs, as well as these companies have overcome many unbelievable challenges since then. So, it’s exciting and uplifting to change the narrative for a moment by recognizing these deserving award winners and sharing these amazing technologies with our colleagues.”
"The idea is simple, while the science is pure genius”, commented Dr. John Flucke, Best of Class panel member, Technology Editor and Chief Dental Editor of Dental Products Report. “Nobio has developed a chemical with antibacterial properties and incorporated it into Infinix composite. Most composite restorations last just 5 to 7 years due to recurrent caries at the restoration/tooth interface. Infinix solves that problem by basically killing any bacteria that comes in contact with the restoration.”
Watch the Infinix award winning announcement here and the whole 2020 Best of Class Award ceremony on Dental Products Report.
About the Cellerant Best of Class Technology Award
Since the inaugural presentation in 2009, the Best of Class Technology Awards have grown to occupy a unique space in dentistry by creating awareness to the dental community what technologies and products of the thousands available can truly impact how practices will operate now and in the future.
The selection process relies on an expert panel of dentists recognized as thought leaders and educators. It includes, Dr. John Flucke, Dr. Marty Jablow, Dr. Paul Feuerstein, Dr. Chris Salierno, Dr. Pamela Maragliano- Muniz, and Dr. Lou Shuman. Over the course of each year, the panel members seek out and conduct research on potentially practice-changing technologies, with deliberations on nominees and final voting taking place in February. Panelists are precluded from voting in any category where they have consulting relationships. The entire selection process is conducted and managed on a not-for-profit basis.
About Cellerant Consulting Group
Founded and led by CEO Dr. Lou Shuman, DMD, CAGS, Cellerant provides strategic dental market insights, clinical expertise, implementation resources and support to accelerate growth for client dental companies. Cellerant services include new concept incubation, clinical product evaluation, product development, continuing education program development and CE sponsorship, strategic branding and marketing, online marketing, content marketing and dental media relations management. As an orthodontist and former owner of a 10- doctor multi-specialty private group practice, Dr. Shuman guides clients to offer products that engage dental customers and provide sustained differentiation. Cellerant operates under a unique model that merges leading voices in clinical product evaluation and strategic partner companies to provide a menu of services from one easily accessible network.
About Nobio
Nobio is a material sciences company that redefines the field of antimicrobial products and solutions with its long-lasting, safe, and highly active novel particle technology. Nobio developed and is commercializing Infinix, the first line of dental materials with its revolutionary antimicrobial technology to address the main causes of dental treatment failure and tooth loss. Nobio is also working with leading medical, dental, consumer, and industrial manufacturers to bring long-lasting antimicrobial properties to a wide range of products and applications. For more information, visit www.nobio.com
Contact
Hanna Elbaz
(844) INFINIX
hanna@nobio.com
Thais Carter, Senior Executive Consultant Cellerant Consulting Group
800-884-5707 x107
thais@cellerantconsulting.com
Airing on Fox Business Network on Sunday, February 16, 2020 at 5:30 pm EST.
Read MoreFDA Clears Infinix™ Antibacterial Universal Bond
Read More
